Shionogi to Acquire IntraBio for $2 Billion
Shionogi has agreed to acquire U.S.-based drugmaker IntraBio for $2 billion to strengthen its rare disease pipeline.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.